Business Wire (Thu, 30-Jan 6:00 AM ET)
Remodel Health Raises More Than $100 Million to Continue Expansion in ICHRA Market
PRNewswire (Thu, 19-Dec 9:00 AM ET)
Hercules Capital Renews and Increases Its Multi-Currency SMBC Credit Facility to $300.0 Million
Business Wire (Mon, 2-Dec 4:07 PM ET)
Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital
Globe Newswire (Thu, 14-Nov 4:05 PM ET)
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
Globe Newswire (Fri, 8-Nov 8:30 AM ET)
History Shows HTGC could rally into earnings
Market Chameleon (Wed, 19-Jul 9:22 AM ET)
Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
Hercules Capital trades on the NYSE stock market under the symbol HTGC.
As of February 4, 2025, HTGC stock price climbed to $21.00 with 553,901 million shares trading.
HTGC has a beta of 0.75, meaning it tends to be less sensitive to market movements. HTGC has a correlation of 0.22 to the broad based SPY ETF.
HTGC has a market cap of $3.52 billion. This is considered a Mid Cap stock.
Last quarter Hercules Capital reported $125 million in Revenue and $.51 earnings per share. This beat revenue expectation by $1 million and met earnings estimates .
In the last 3 years, HTGC traded as high as $21.78 and as low as $10.94.
The top ETF exchange traded funds that HTGC belongs to (by Net Assets): BIZD, PBDC, VPC, ISMD, KRUZ.
HTGC has outperformed the market in the last year with a price return of +32.2% while the SPY ETF gained +23.1%. HTGC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +11.7% and +1.2%, respectively, while the SPY returned +5.7% and +0.7%, respectively.
HTGC support price is $20.73 and resistance is $21.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HTGC shares will trade within this expected range on the day.